Cleocin Phosphate

Babesiosis, Mitral Valve Prolapse, Toxoplasmosis + 39 more

Treatment

20 Active Studies for Cleocin Phosphate

What is Cleocin Phosphate

Clindamycin

The Generic name of this drug

Treatment Summary

Clindamycin is a type of antibiotic used to treat serious bacterial infections. It is also used on the skin to treat acne. Clindamycin works against bacteria, gram-positive cocci, and bacilli, as well as some protozoans. It is a semi-synthetic medication that was made to replace lincomycin which comes from a type of bacteria found in soil from Lincoln, Nebraska.

Cleocin Hydrochloride

is the brand name

Cleocin Phosphate Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Cleocin Hydrochloride

Clindamycin

1970

507

Effectiveness

How Cleocin Phosphate Affects Patients

Clindamycin is an antibiotic that works by stopping bacteria from making proteins. It has to be taken every six hours to make sure it is working effectively. Clindamycin can cause severe diarrhea, even up to two months after taking the medication which can be life-threatening. It mostly works on gram-positive bacteria and some anaerobic bacteria, but there can be resistance. Before taking this medication, it is important to check the local antibiotic resistance patterns for common pathogens.

How Cleocin Phosphate works in the body

Clindamycin works by blocking the production of proteins in bacteria. It does this by attaching to the ribosomes, which are the parts of cells that make proteins. It then prevents the ribosomes from making proteins. For acne, it is thought that clindamycin works by killing the bacteria that causes acne.

When to interrupt dosage

The dosage of Cleocin Phosphate is contingent upon the determined situation, such as viridans group streptococci, Vaginal Infections and Surgical Intervention. The measure shifts as indicated by the technique for delivery (e.g. Cream - Vaginal or Suspension - Topical) recorded in the table beneath.

Condition

Dosage

Administration

viridans group streptococci

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Heart Valve Prosthesis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Communicable Diseases

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Bacteria, Anaerobic

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Respiratory Tract Infections

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Malaria

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Bone and Bones

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Heart Defects, Congenital

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Acne Vulgaris

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

penicillins

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Hypertrophic Cardiomyopathy

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Surgical Intervention

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Bone and Bones

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Endometritis caused by Anaerobic Bacterial Infection

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

prophylaxis of Bacterial endocarditis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Acne Vulgaris

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Endocarditis, Bacterial

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Candidiasis, Vulvovaginal

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Pneumonia, Pneumocystis

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Mixed Vaginal Infections

150.0 mg, 300.0 mg, , 0.02 mg/mg, 75.0 mg/mL, 150.0 mg/mL, 75.0 mg, 0.01 mg/mg, 10.0 mg/mL, 6.0 mg/mL, 12.0 mg/mL, 18.0 mg/mL, 100.0 mg/mL, 10.0 mg, 0.1 mg/mg, 100.0 mg, 1.0 %, 1.2 %, 30.0 mg/mL, 60.0 mg/mL, 90.0 mg/mL, 0.012 mg/mg, 11.9 mg/mL, 5.0 mg/mg, 0.007 mg/mg, 0.01 mg/mL

, Capsule - Oral, Oral, Capsule, Vaginal, Cream, Cream - Vaginal, Injection, solution, concentrate - Intravenous, Intravenous, Topical, Gel - Topical, Gel, Suspension, Suspension - Topical, Solution, Solution - Topical, Injection, solution, Injection, solution - Intravenous, Solution - Oral, Swab - Topical, Swab, Kit, Kit - Topical, Aerosol, foam, Aerosol, foam - Topical, Lotion, Lotion - Topical, Granule, for solution - Oral, Granule, for solution, Capsule, gelatin coated - Oral, Kit - Intramuscular; Intravenous, Powder, for solution - Oral, Powder, for solution, Solution - Intramuscular; Intravenous, Liquid - Intramuscular; Intravenous, Solution - Intravenous, Cream - Topical, Intramuscular; Intravenous, Injection, solution - Intramuscular; Intravenous, Injection, Injection - Intravenous, Injection, solution, concentrate, Suppository, Suppository - Vaginal, Capsule, gelatin coated, Liquid, Injection - Intramuscular; Intravenous, Kit - Infiltration; Intramuscular; Intravenous, Infiltration; Intramuscular; Intravenous, Gel - Vaginal, Injection, solution, concentrate - Intramuscular; Intravenous

Warnings

Cleocin Phosphate has four contraindications, thus it should not be administered for any of the conditions mentioned in the following table.

Cleocin Phosphate Contraindications

Condition

Risk Level

Notes

Enterocolitis, Pseudomembranous

Do Not Combine

Crohn Disease

Do Not Combine

Ulcerative Colitis

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Clindamycin may interact with Pulse Frequency

There are 20 known major drug interactions with Cleocin Phosphate.

Common Cleocin Phosphate Drug Interactions

Drug Name

Risk Level

Description

Astemizole

Major

The metabolism of Astemizole can be decreased when combined with Clindamycin.

Axitinib

Major

The metabolism of Axitinib can be decreased when combined with Clindamycin.

Bromocriptine

Major

The serum concentration of Bromocriptine can be increased when it is combined with Clindamycin.

Cabazitaxel

Major

The metabolism of Cabazitaxel can be decreased when combined with Clindamycin.

Cabergoline

Major

The serum concentration of Cabergoline can be increased when it is combined with Clindamycin.

Cleocin Phosphate Toxicity & Overdose Risk

The toxic dose of clindamycin in mice and rats has been measured at 2540 mg/kg and 2190 mg/kg, respectively. While no overdose cases have been reported, symptoms may include abdominal pain, nausea, vomiting, or diarrhea. In one instance, a 3-year-old child was given 100 mg/kg of the drug daily for 5 days and only experienced mild abdominal pain and diarrhea. Activated charcoal can be used to remove unabsorbed clindamycin from the body, but dialysis is not effective. In cases of overdose, general supportive care is recommended.

Cleocin Phosphate Novel Uses: Which Conditions Have a Clinical Trial Featuring Cleocin Phosphate?

73 active studies are being conducted to determine the efficacy of Cleocin Phosphate in providing relief for Bacterial Endocarditis, Acne and Pneumocystis Jirovecii Pneumonia.

Condition

Clinical Trials

Trial Phases

Respiratory Tract Infections (RTI) caused by susceptible streptococci

0 Actively Recruiting

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

Mitral Valve Prolapse

1 Actively Recruiting

Not Applicable

Hypertrophic Cardiomyopathy

4 Actively Recruiting

Not Applicable, Phase 1, Phase 2

Surgically constructed systemic-pulmonary shunt

0 Actively Recruiting

Respiratory Tract Infections

0 Actively Recruiting

Bacteria, Anaerobic

0 Actively Recruiting

Heart Defects, Congenital

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Bone and Bones

0 Actively Recruiting

Babesiosis

1 Actively Recruiting

Phase 2

Mixed Vaginal Infections

0 Actively Recruiting

Toxoplasmosis

1 Actively Recruiting

Phase 4

Surgical Intervention

0 Actively Recruiting

Pelvic cellulitis caused by Anaerobic Bacterial Infection

0 Actively Recruiting

Bacterial Endocarditis

0 Actively Recruiting

Malaria

0 Actively Recruiting

Acne Vulgaris

0 Actively Recruiting

Vaginal Infections

0 Actively Recruiting

Acquired Immunodeficiency Syndrome

5 Actively Recruiting

Phase 1, Phase 2, Not Applicable

Patient Q&A Section about cleocin phosphate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is Cleocin Phosphate used for?

"It will not work for viral infections (such as common cold, flu).

This medication is used to treat bacterial infections. It works by stopping the growth of bacteria. This antibiotic only treats bacterial infections and won't work for viral infections."

Answered by AI

Is Cleocin a penicillin?

"Is Cleocin the same as penicillin?

Cleocin (clindamycin hydrochloride) and penicillin are both antibiotics used to treat serious infections caused by bacteria. However, they belong to different antibiotic drug classes. Cleocin is a lincomycin antibiotic and penicillin is a penicillin antibiotic."

Answered by AI

Is Cleocin a strong antibiotic?

"Yes, Clindamycin is a powerful broad-based antibiotic that is prescribed by doctors to treat severe infections, including MRSA infections that can be fatal. It is effective against various bacterial infections, including those that can survive without air."

Answered by AI

What infections does Cleocin treat?

"Clindamycin is an antibiotic that is used to treat infections that are serious. This antibiotic is effective against a few different kinds of bacteria, such as Staphylococcus aureus, Streptococcus pneumoniae, Staphylococcus epidermidis, and Propionibacterium acnes. Clindamycin works by reducing the growth of bacteria by interfering with their ability to make proteins."

Answered by AI

Clinical Trials for Cleocin Phosphate

Image of New Jersey Community Research Initiative in Newark, United States.

AI-DBT for Suicide Prevention in HIV/AIDS

18+
All Sexes
Newark, NJ

One in four older persons living with HIV/AIDS (PLWHA) report at least one suicide attempt in their lifetime, and the risk for death by suicide is 100 times higher in PLWHA than in the general population. Currently, there are no behavioral interventions that specifically address suicide prevention for older PLWHA, despite their unique biopsychosocial and structural risk factors. Through this work, investigators will adapt Dialectical Behavior Therapy, an evidence-based intervention for suicide prevention, for patients with PLWHA to be delivered by an AI-powered conversational Agent developed by our industry partner, Empower Health. Investigators will then pilot test the feasibility, usability, acceptability and preliminary efficacy to improve self-efficacy to manage negative emotions in n=50 older adults living with HIV/AIDS.

Recruiting
Has No Placebo

New Jersey Community Research Initiative (+1 Sites)

Elissa Kozlov, PhD

Image of McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital in Montreal, Canada.

Systemic Corticosteroids for Pneumocystis Pneumonia

18+
All Sexes
Montreal, Canada

The HOW LONG trial is an international, multicenter, Phase IV randomized clinical trial evaluating the optimal duration of adjunctive systemic corticosteroids in immunocompromised adults with severe Pneumocystis jirovecii pneumonia (PCP) who demonstrate early clinical recovery. Participants who no longer require supplemental oxygen by day 10 of corticosteroid therapy are randomized to discontinue corticosteroids at day 10 (or hospital discharge, if earlier) versus continue corticosteroids for a total of 21 days. The trial assesses whether earlier discontinuation reduces steroid-related complications while maintaining clinical outcomes.

Phase 4
Waitlist Available

McGill university Health Centre (Royal victoria Hospital and Montreal General Hospital

Image of Los Angeles General Medical Center in Los Angeles, United States.

Decision Support Tool for HIV Treatment

18+
All Sexes
Los Angeles, CA

This study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients. HIV medicines, known as antiretroviral therapy (ART), can be complex to manage because the right regimen depends on many factors-such as drug resistance, other health conditions, and medication schedules. Many people with HIV are cared for by general clinicians who may not have access to HIV specialists, which can make treatment decisions more challenging. In this study, healthcare providers will use patient cases to compare standard HIV treatment resources with a new clinical decision support tool that gives evidence-based ART recommendations at the point of care. The investigators hypothesize that using the tool will help providers select treatment plans that better match clinical guidelines, make decisions faster, reduce mental effort, and increase overall satisfaction with the prescribing process.

Waitlist Available
Has No Placebo

Los Angeles General Medical Center

Hayoun Lee, PhD

Have you considered Cleocin Phosphate clinical trials?

We made a collection of clinical trials featuring Cleocin Phosphate, we think they might fit your search criteria.
Go to Trials
Image of Montefiore Medical Center in Bronx, United States.

myPACE+ Algorithm for Hypertrophic Cardiomyopathy

18+
All Sexes
Bronx, NY

This will be a two-arm investigator-initiated randomized controlled study of patients with nHCM and LV ejection fraction ≥50% and NYHA II-III symptoms, normal intrinsic conduction system and pre-existing suitable dual-chamber implantable cardioverter defibrillators (ICD) systems. Patients will be randomly assigned to either personalized accelerated pacing (using the myPACE+ algorithm with mono-fractional exponent) or usual care groups. At baseline and after 3 months of pacing all patients will undergo a CPET, echocardiogram, blood work for NT-proBNP levels and complete the KCCQ-OSS and HCMSQ, questionnaires. The investigator team hypothesizes that personalized accelerated pacing will be safe and improve symptoms and heart-failure related quality of life, physical activity, pVO2, biomarkers (i.e. NT-proBNP), diastolic parameters and cardiac structure.

Recruiting
Has No Placebo

Montefiore Medical Center (+1 Sites)

Sandhya Murthy, MD

Medtronic

Image of Texas Tech University Health Sciences Center in Lubbock, United States.

Amoxicillin Challenge for Penicillin Allergy

18 - 89
All Sexes
Lubbock, TX

The goal of this clinical trial is to learn about dosing when testing to see if a penicillin allergy label can be removed from adults that had been labeled as "penicillin-allergic" previously. The main question it aims to answer is: \- In penicillin-allergic patients that are at low risk of having an allergic reaction, is a one-dose oral challenge with amoxicillin (a penicillin-based antibiotic) as safe and effective as a two-dose oral challenge? Participants will, after being identified as having a low-risk penicillin allergy, be administered oral amoxicillin in a controlled setting and then monitored for an allergic reaction. Researchers will compare participants that took one dose of amoxicillin to participants that took two doses of amoxicillin (a small dose and then a larger dose) to see if either group was more likely to develop an allergic reaction.

Phase 3
Recruiting

Texas Tech University Health Sciences Center

James A Tarbox, MD

Have you considered Cleocin Phosphate clinical trials?

We made a collection of clinical trials featuring Cleocin Phosphate, we think they might fit your search criteria.
Go to Trials
Image of University of California - San Francisco in San Francisco, United States.

Exercise Program for Hypertrophic Cardiomyopathy

18 - 80
All Sexes
San Francisco, CA

The EXCITE-HCM study is a randomized, controlled, blinded clinical trial designed to evaluate the effect of moderate intensity exercise training versus usual physicial activity on the improvement of HCM-related symptoms and cardiac function. About 70 participants will be recruited and randomized on a 1:1 ratio to either moderate intensity training or usual physicial activity interventions. Patients will be followed during a period of 24 weeks and assesesments as physical examination, questionnaires, 12 lead ecg's, biomarker levels, echocardiogram, Cardiac Magnetic resonance, PET and CPET will be performed to evaluate their response to the intervention.

Recruiting
Has No Placebo

University of California - San Francisco

Theodore P Abraham, M.D

Have you considered Cleocin Phosphate clinical trials?

We made a collection of clinical trials featuring Cleocin Phosphate, we think they might fit your search criteria.
Go to Trials